Rain to start clearing tomorrow but Gauteng will continue to experience La Niña
Shortage of jobs worsens humiliation of black people through cheap labour
My foreign staff with legal working visas are afraid of EFF visit - KREAM owner
'Firms implicated in state capture shouldn't be allowed to do business in SA'
Bain drops membership of Business Leadership SA amid state capture fallout
Home of ex-Sars exec broken into days after another whistleblower targeted
All this lovely rain – it’s too much, and might mean higher food prices
'Rights offer deal will see Tongaat Hulett owned by notorious Zimbabwe family'
Used car sales are booming - and prices are skyrocketing
You shouldn't make your bed first thing in the morning, warns cleaning expert
Some people wrongly avoid a number of things thinking they have allergy - Expert
WATCH: 'Askies, I'm sorry' Actor Patrick Shai apologies to Cassper Nyovest
Australia cancels Novak Djokovic's visa again, deportation looms
Sascoc: Allowing spectators at sporting venues could motivate others to get jabs
Vincent Aboubakar penalties give Cameroon 2-1 victory against Burkina Faso
I never want to write music that will make someone feel worse - Ross Harding
A chance to tick a bucketlist music concert off your list in 2022
WATCH: Lady searching for 'dream man' on TiKTok shocked when wife reaches out
How different is it to drive an electric car?
Pig's heart transplanted into human 'is genetically modified'
Elon Musk's SpaceX to launch CPUT's 3rd satellite mission into space on Thursday
'I'm not leaving politics,' says Maimane after joining SiSebenza as a partner
Was Kenya blackout result of independent power producers fighting price cuts?
'We just don't have a government in Zimbabwe', says caller
[BOOK REVIEW] Make tiny changes – get remarkable results, over time
'Eskom must not be allowed to punish consumers for its failures'
'I closed my account, how did fraudster get card in my name and spend 1000s?'
Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
JSE-listed Aspen Pharmacare has struck a deal with US multinational Johnson & Johnson to commercially manufacture its vaccine candidate.
Johnson & Johnson’s “Ad26.COV2-S” vaccine is undergoing clinical trials.
Aspen Pharmacare will make the vaccines at an existing factory in Port Elizabeth if trials are successful and manufacturing terms are finalised.
The facility is capable of making 300 million vaccine doses per year.
Aspen Pharmacare’s share price was up 11.45% on Monday.
The Money Show’s Bruce Whitfield interviewed Stephen Saad, CEO at Aspen Pharmacare.
Johnson & Johnson’s is a $400 billion company… We’re well-positioned… The tech transfer – we’ve started the process…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson… we like their candidate. You only need one shot… and a fridge… They’ve got 60 000 people in their Phase-3 trial…
Stephen Saad, CEO - Aspen Pharmacare
Johnson & Johnson promised universal access…
Stephen Saad, CEO - Aspen Pharmacare
We’ll be ready to put a vaccine into the world by March or April next year…
Stephen Saad, CEO - Aspen Pharmacare
Listen to the interview in the audio below.
This article first appeared on CapeTalk : Aspen Pharmacare shares up 11% on Covid-19 vaccine deal with Johnson & Johnson
Copyright : https://www.123rf.com/license.php#standardSource : https://www.123rf.com/photo_53976118_little-happy-girl-get-an-injection-vaccination.html?term=vaccine%2Bsmile&vti=mpp4sbopzossai9spw-1-1
More from MyMoney Online
Squid Game crypto scammers make off with R32 million
The Money Show’s Bruce Whitfield interviews Farzam Ehsani, cofounder and CEO at VALR.com.
Read More
Women earn less than men – and therefore have worse pension outcomes
The Money Show’s Bruce Whitfield interviewed Vickie Lange of Alexander Forbes.
Read More
Get rich by investing globally – a guide for beginners on how to invest overseas
Get a good income from your investments – despite low interest rates
The Money Show’s Bruce Whitfield interviews personal finance advisor Warren Ingram.
Read More
Pay less for car insurance - if you're a good driver and/or you don't drive much
Arabile Gumede interviews Christiaan Steyn, Head of at MiWay Blink.
Read More
How investing a third of everything I earned changed my life, forever
The Money Show’s Bruce Whitfield interviews "supersaver" Julia, as he does once every year in July.
Read More
'Offshore investing is a great idea – but be careful where you put your money'
More from Covid-19 coronavirus explained
Is Omicron how the Covid-19 pandemic finally ends?
The Money Show’s Bruce Whitfield interviews Netcare CEO Dr Richard Friedland.
Read More
4 likely scenarios for interest rates in the time of Omicron
The Money Show’s Bruce Whitfield interviews Alexander Forbes Chief Economist Isaah Mhlanga.
Read More
Fear mongering is threatening livelihoods - Marc Waschsberger (The Capital)
The Money Show’s Bruce Whitfield interviews Marc Waschsberger, Managing Director at The Capital.
Read More
Mandate vaccines at work and in public indoor spaces - Business for South Africa
The Money Show’s Bruce Whitfield interviews Martin Kingston of Business for South Africa (B4SA).
Read More
4th wave of Covid-19 in SA is imminent – perhaps already on its way in Gauteng
Aspen releases first batch of locally finished J&J Covid-19 vaccines for Africa
The Money Show’s Bruce Whitfield interviews Aspen Pharmacare's Stavros Nicolau.
Read More
More from Information about Covid-19 coronavirus
Is Omicron how the Covid-19 pandemic finally ends?
The Money Show’s Bruce Whitfield interviews Netcare CEO Dr Richard Friedland.
Read More
4 likely scenarios for interest rates in the time of Omicron
The Money Show’s Bruce Whitfield interviews Alexander Forbes Chief Economist Isaah Mhlanga.
Read More
Fear mongering is threatening livelihoods - Marc Waschsberger (The Capital)
The Money Show’s Bruce Whitfield interviews Marc Waschsberger, Managing Director at The Capital.
Read More
4th wave of Covid-19 in SA is imminent – perhaps already on its way in Gauteng
Aspen releases first batch of locally finished J&J Covid-19 vaccines for Africa
The Money Show’s Bruce Whitfield interviews Aspen Pharmacare's Stavros Nicolau.
Read More
'We can’t take an extension of lockdown. We’re out of ideas!'
Ray White interviews Marc Waschsberger, Managing Director at The Capital.
Read More
Highlights